Dr. Reddy’s Laboratories (NYSE: RDY) shares link to July 9, 2026 conference call audio

Rhea-AI Filing Summary

Dr. Reddy’s Laboratories Limited, a foreign private issuer, submitted a Form 6-K noting that an audio recording of its conference call held on July 9, 2026 is available online. The company provided a specific web link to the recording for the information and records of investors and stock exchanges.

Key Terms

foreign private issuer, Regulation 30, Listing Obligations and Disclosure Requirements Regulations, 2015

3 terms

foreign private issuer regulatory

"REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16"

A foreign private issuer is a company organized outside the United States that meets tests showing it is primarily foreign-controlled and therefore qualifies for a different set of U.S. reporting rules. For investors, that means the company files less frequent or differently formatted disclosures with U.S. regulators and may follow home-country accounting and governance practices, so buying its stock is like dining at a well-reviewed restaurant that follows its home kitchen’s rules instead of the local menu — you get access but should check what standards apply.

Regulation 30 regulatory

"Pursuant to Regulation 30 of the Securities and Exchange Board of India"

Listing Obligations and Disclosure Requirements Regulations, 2015 regulatory

"Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 6-K: How Foreign Companies Report to the SEC →

Available on EDGAR 07/10/2026 - 06:21 AM Accepted by SEC EDGAR 07/10/2026 - 06:20 AM Learn about SEC filing dates

FAQ

What does Dr. Reddy’s (RDY) report in this Form 6-K?

Dr. Reddy’s Laboratories reported that an audio recording of its conference call held on July 9, 2026 is available via a web link for investors’ information and records.

What is the subject of Dr. Reddy’s (RDY) July 10, 2026 communication?

The subject is the audio recording of a conference call conducted on July 9, 2026, with the company sharing a URL so exchanges and investors can access the recording.

Which regulation is cited by Dr. Reddy’s (RDY) for this disclosure?

The company cites Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as the basis for disclosing the conference call recording link.

Which stock exchanges received this Dr. Reddy’s (RDY) intimation?

The intimation was sent to National Stock Exchange of India Ltd., BSE Limited, New York Stock Exchange Inc., and NSE IFSC Ltd., each referenced with the company’s respective stock codes.

What online resource did Dr. Reddy’s (RDY) provide in the July 10, 2026 notice?

Dr. Reddy’s provided a specific web link to an MP3 audio file containing the recording of its July 9, 2026 conference call, for information and record-keeping purposes.

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

July, 2026

Commission File Number 1-15182

DR. REDDY’S LABORATORIES LIMITED

(Translation of registrant’s name into English)

8-2-337, Road No. 3, Banjara Hills

Hyderabad, Telangana 500 034, India

+91-40-49002900

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F  x                             Form 40-F   ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ______

Note:  Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ______

Note:  Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes  ¨                             No   x

If “Yes” is marked, indicate below the file number assigned to registrant in connection with Rule 12g3-2(b): 82-_________.

EXHIBITS

Exhibit Number		Description of Exhibits
99.1		Intimation dated July 10, 2026

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	DR. REDDY’S LABORATORIES LIMITED (Registrant)
Date: July 10, 2026	By:	/s/ K Randhir Singh
		Name:	K Randhir Singh
		Title:	Company Secretary

3

Exhibit 99.1

Dr. Reddy's Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills Hyderabad – 500 034, Telangana, India CIN: L85195TG1984PLC004507 Tel:       + 91 40 4900 2900 Fax:     + 91 40 4900 2999 Email: mail@drreddys.com Web:   www.drreddys.com

July 10, 2026

National Stock Exchange of India Ltd. (Stock Code: DRREDDY)

BSE Limited (Stock Code: 500124)

New York Stock Exchange Inc. (Stock Code: RDY)

NSE IFSC Ltd. (Stock Code: DRREDDY)

Dear Sir/ Madam,

Sub: Audio Recording of the conference call conducted on July 9, 2026

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find below the link of the audio recording of the conference call, conducted on July 9, 2026.

Weblink:

https://www.drreddys.com/cms/sites/default/files/2026-07/GMT20260709-110137_Recording.mp3

This is for your information and records.

Yours faithfully,

For Dr. Reddy’s Laboratories Limited

K Randhir Singh

Company Secretary, Compliance Officer & Head-CSR

Filing Exhibits & Attachments

1 document

Press Releases

• EX-99.1 EXHIBIT 99.1 14.6 KB